Literature DB >> 18071118

Orbital and adnexal sarcoidosis.

Venkatesh C Prabhakaran1, Perooz Saeed, Bita Esmaeli, Timothy J Sullivan, Alan McNab, Garry Davis, Alejandra Valenzuela, Igal Leibovitch, Anat Kesler, Jennifer Sivak-Callcott, Erika Hoyama, Dinesh Selva.   

Abstract

OBJECTIVE: To present the clinical features and management in a series of patients with orbital and adnexal sarcoidosis.
METHODS: This multicenter retrospective study included patients with biopsy-proven noncaseating granuloma involving the orbit or adnexa and evidence of systemic sarcoidosis. Clinical records were reviewed for initial examination findings, radiological findings, treatment modalities, and outcome.
RESULTS: The study included 26 patients (19 female, 7 male; mean age, 52 years). The most common feature at the first examination was a palpable periocular mass followed by discomfort, proptosis, ptosis, dry eye, diplopia, and decreased vision. The disease affected the lacrimal gland (42.3%), orbit (38.5%), eyelid (11.5%), and lacrimal sac (7.7%). Among orbital lesions, the antero-inferior quadrant was preferentially involved. Treatment modalities included steroids, surgical debulking, and methotrexate. During a mean follow-up of 18.75 months, 84.6% of patients showed a complete response to the treatment, but 19.2% of patients developed further signs of sarcoidosis.
CONCLUSIONS: Orbital soft tissue involvement is more common in patients older than 50 years and in women. The anterior inferior quadrants of the orbits appear to be preferentially affected. Although a good response to treatment with oral steroids is seen, long-term follow-up is recommended because active systemic disease can develop months to years later.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18071118     DOI: 10.1001/archopht.125.12.1657

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  24 in total

Review 1.  Ocular Sarcoidosis.

Authors:  Sirichai Pasadhika; James T Rosenbaum
Journal:  Clin Chest Med       Date:  2015-12       Impact factor: 2.878

Review 2.  The 2017 Doyne Lecture: the orbit as a window to systemic disease.

Authors:  A A McNab
Journal:  Eye (Lond)       Date:  2017-11-10       Impact factor: 3.775

Review 3.  Periocular cutaneous sarcoid: case series and review of the literature.

Authors:  Rehan Rajput; Priscilla Mathewson; Hardeep Singh Mudhar; Paul Hiley; Soupramanien Sandramouli; Rina Bhatt
Journal:  Eye (Lond)       Date:  2019-05-02       Impact factor: 3.775

Review 4.  The Clinical Features of Sarcoidosis: A Comprehensive Review.

Authors:  Marc A Judson
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

5.  Recurrent dacryostenosis as initial presentation of sarcoidosis.

Authors:  Marie Julie Blouin; Daniel O Black; Gaetan Fradet
Journal:  Case Rep Otolaryngol       Date:  2012-09-09

Review 6.  Ocular complications of childhood rheumatic diseases: nonuveitic inflammatory eye diseases.

Authors:  Andreas Reiff
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

7.  The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca.

Authors:  Koray Gumus; Dwight H Cavanagh
Journal:  Clin Ophthalmol       Date:  2009-06-02

Review 8.  Extrapulmonary manifestations of sarcoidosis.

Authors:  Deepak A Rao; Paul F Dellaripa
Journal:  Rheum Dis Clin North Am       Date:  2013-03-13       Impact factor: 2.670

9.  Orbital sarcoidosis presenting as diffuse swelling of the lower eyelid.

Authors:  Jeong Kyu Lee; Nam Ju Moon
Journal:  Korean J Ophthalmol       Date:  2013-01-15

Review 10.  Orbital myositis: diagnosis and management.

Authors:  Roberta M S Costa; Oana M Dumitrascu; Lynn K Gordon
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.